Physician profile
Christopher L Cooley
NPI 1194733543
$2,033.67
in general payments reported to CMS, 2019-2025
15 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $213 · 2021: $226 · 2022: $136 · 2023: $336 · 2024: $556 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,274.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $972.06 | 2019-2025 | Clareon, Clareon Panoptix Pro, Hydrus Microstent |
| Abbvie INC. | $479.96 | 2022-2025 | Durysta, Xen Glaucoma Treatment System |
| Allergan, INC. | $144.63 | 2019-2021 | |
| New World Medical,INC. | $118.72 | 2025 | Via360, Streamline, Ahmed Glaucoma Valve |
| Johnson & Johnson Surgical Vision, INC. | $77.57 | 2021-2025 | Tecnis Simplicity, Tecnis Iol |
| Bausch & Lomb Americas INC. | $62.59 | 2022-2024 | Infuse |
| Ocular Therapeutix, INC. | $29.93 | 2023 | Dextenza |
| Dompe US, INC. | $29.45 | 2025 | Oxervate |
| Biogen, INC. | $21.01 | 2022 | |
| Sight Sciences, INC. | $20.69 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Aerie Pharmaceuticals, INC. | $17.81 | 2020 | |
| Oyster Point Pharma, INC. | $17.36 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $15.50 | 2019 | |
| Horizon Therapeutics Plc | $13.84 | 2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.